4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-12-004229
Sr. VP, Drug Development sold 6,844 shares at $4.70 ($32,187)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koya Keizo Sr. VP, Drug Development | 2012-03-01 | Sale | −6,844 | $4.70 | $32,187 | 12,999 | D: show line 1 in the form |
| Open-market sales · 6,844 sh · avg $4.70 · $32,187 | |||||||
Loading xslF345X03/edgar.xml…